Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | v465447_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | v465447_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | v465447_ex31-1.htm |
| EX-10.1 - EXHIBIT 10.1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | v465447_ex10-1.htm |
| 10-Q - 10-Q - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | v465447_10q.htm |
Exhibit 32.1
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with this Quarterly Report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Timothy Warbington, Chief Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | Such Quarterly Report on Form 10-Q for the period ended March 31, 2017, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2017 fairly presents, in all material respects, the financial condition and results of operations of Creative Medical Technology Holdings, Inc. |
| Date: May 10, 2017 | By: | /s/ Timothy Warbington |
|
Timothy Warbington Chief Executive Officer (Principal Executive Officer) |